Double immunofluorescence staining with YAP and nephrin (a podocyte marker) further confirmed that YAP is mainly located in podocyte nuclei in MCD patients, but in podocyte cytoplasm in FSGS patients (Fig. 1B, C). The gene discussed is NPHS1; the disease is focal segmental glomerulosclerosis.